These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24692812)

  • 1. A probable case of oral bisphosphonate-associated osteonecrosis of the jaw and recovery with parathyroid hormone treatment.
    Song KE; Min YK; Lee JK; Lee KB; Joo HJ; Kwack KS; Chung YS
    Curr Ther Res Clin Exp; 2008 Aug; 69(4):356-62. PubMed ID: 24692812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.
    Lehrer S; Montazem A; Ramanathan L; Pessin-Minsley M; Pfail J; Stock RG; Kogan R
    J Oral Maxillofac Surg; 2009 Jan; 67(1):159-61. PubMed ID: 19070762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Sánchez A; Blanco R
    Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P; Nammour S
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.
    Lehrer S; Montazem A; Ramanathan L; Pessin-Minsley M; Pfail J; Stock RG; Kogan R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Sep; 106(3):389-91. PubMed ID: 18554944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and osteonecrosis of the jaw: a retrospective study.
    Murad OM; Arora S; Farag AF; Guber HA
    Endocr Pract; 2007; 13(3):232-8. PubMed ID: 17599853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing.
    Kuroshima S; Entezami P; McCauley LK; Yamashita J
    Osteoporos Int; 2014 Mar; 25(3):1141-50. PubMed ID: 24301537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    Marx RE; Cillo JE; Ulloa JJ
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2397-410. PubMed ID: 18022461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Bisphosphonate Induced Recurrent Osteonecrosis of Jaw with Atypical Femoral Fracture and Subsequent Mandible Fracture in the Same Patient: A Case Report.
    Pispati A; Pandey V; Patel R
    J Orthop Case Rep; 2018; 8(3):85-88. PubMed ID: 30584526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Udvardy E; Redl P; Márton I
    Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report.
    Pan WL; Chen PL; Lin CY; Pan YC; Ju YR; Chan CP; Hsu RW
    Clin Interv Aging; 2017; 12():1089-1093. PubMed ID: 28744112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
    Cremers S; Farooki A
    Ann N Y Acad Sci; 2011 Feb; 1218():80-7. PubMed ID: 20946577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
    Thumbigere-Math V; Michalowicz BS; Hughes PJ; Basi DL; Tsai ML; Swenson KK; Rockwell L; Gopalakrishnan R
    J Oral Maxillofac Surg; 2016 Apr; 74(4):738-46. PubMed ID: 26501428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis: A Nested Case-control Study.
    Kwon JW; Park EJ; Jung SY; Sohn HS; Ryu H; Suh HS
    J Dent Res; 2015 Sep; 94(9 Suppl):212S-9S. PubMed ID: 26001708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
    Hoefert S; Schmitz I; Tannapfel A; Eufinger H
    Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Shudo A; Kishimoto H; Takaoka K; Noguchi K
    Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.